Pre-Morbid Developmental Vulnerabilities in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Authors:
- 25 August 2015
- journal article
- clinical trial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 62 (12) , 2183-2188
Abstract
Not all children with acute lymphoblastic leukemia (ALL) were developing in a typical manner prior to diagnosis. Pre-existing developmental vulnerabilities (DV) may be related to long-term neuropsychological sequelae following ALL treatment, yet little is known about the prevalence or nature of prior DV in this population. Children with newly diagnosed ALL aged 2–18 years (n = 115) were screened for DV by asking parents about the child's prior developmental history and with the Developmental Profile-3 (DP-3). Twenty-six participants (23% of total sample) screened positive for prior DV, with one or more of the following: delayed early motor and/or language milestones that required intervention (n = 17), prior diagnosis of Down syndrome (n = 3), prior diagnosis of autism spectrum disorder (n = 1), prior diagnosis of attention-deficit/hyperactivity disorder and/or learning disability (n = 6), or prior neurological conditions (n = 5). A sizable proportion of children with newly diagnosed ALL have pre-morbid DV that could potentially make them more vulnerable to reduced educational opportunities during treatment and neurotoxic late effects following treatment. Identification of the subset of children with ALL and DV is essential to direct early interventions and to study their long-term outcomes. Pediatr Blood CancerKeywords
Funding Information
- Pediatric Oncology Group of Ontario (POGO) and Canadian Cancer Society
This publication has 16 references indexed in Scilit:
- Canadian cancer statistics at a glance: cancer in childrenCanadian Medical Association Journal, 2009
- A meta‐analysis of the neuropsychological sequelae of chemotherapy‐only treatment for pediatric acute lymphoblastic leukemiaPediatric Blood & Cancer, 2008
- Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatmentDevelopmental Disabilities Research Reviews, 2008
- Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01Journal of Clinical Oncology, 2007
- A meta‐analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemiaPediatric Blood & Cancer, 2007
- Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaBlood, 2006
- Brief Report: Effect of Intravenous Methotrexate Dose and Infusion Rate on Neuropsychological Function One Year after Diagnosis of Acute Lymphoblastic LeukemiaJournal of Pediatric Psychology, 2006
- Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PLeukemia & Lymphoma, 2006
- Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective researchArchives of Disease in Childhood, 2005
- Outcomes of a Randomized Trial of Hyperfractionated Cranial Radiation Therapy for Treatment of High-Risk Acute Lymphoblastic Leukemia: Therapeutic Efficacy and NeurotoxicityJournal of Clinical Oncology, 2004